Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a fixed-dose combination product containing pantoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* infection. Pantoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
## Primary Indications
* Eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease or a history of peptic ulcer disease.
## Adult Dosing
The standard adult dose is one kit, taken orally twice daily for 7 days. Each kit typically contains:
* Pantoprazole 40 mg delayed-release tablet
* Amoxicillin 500 mg capsule
* Clarithromycin 500 mg tablet
**Important:** Patients should take all medications as directed. Typically, pantoprazole is taken before breakfast, and amoxicillin and clarithromycin are taken with meals. Specific timing instructions may vary based on the manufacturer's labeling or local protocols.
## Pediatric Dosing
Specific pediatric dosing for Sompraz hp is not established. Treatment decisions in pediatric patients should be individualized and based on expert guidance, considering the individual components of the regimen.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment for pantoprazole is typically recommended in mild to moderate renal impairment. In severe renal impairment, caution may be warranted, though specific dosing adjustments are not well-defined for the combination product. Amoxicillin and clarithromycin doses may require adjustment based on renal function according to their individual prescribing information.
* **Hepatic Impairment:** No dose adjustment for pantoprazole is typically recommended in mild to moderate hepatic impairment. In severe hepatic impairment, caution may be warranted, though specific dosing adjustments are not well-defined for the combination product. Clarithromycin may require dose adjustment in severe hepatic impairment.
## Contraindications
* Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins, cephalosporins, or macrolides.
* Concurrent use of delavirdine.
* Patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Congenital long QT syndrome.
* Electrolyte abnormalities (e.g., hypokalemia, hypomagnesemia).
* Severe renal impairment (for some components).
## Adverse Effects
Common adverse effects may include:
* **Gastrointestinal:** Diarrhea, nausea, abdominal pain, vomiting, taste perversion, dyspepsia.
* **General:** Headache, dizziness, rash, fatigue.
* **Other:** Fungal infections (e.g., Candida).
More serious adverse effects include C. difficile-associated diarrhea, hypersensitivity reactions (including anaphylaxis), liver enzyme elevations, and QT prolongation.
## Key Drug Interactions
* **Pantoprazole:** Can alter the absorption of drugs dependent on gastric pH (e.g., ketoconazole, itraconazole, iron salts, vitamin B12). May affect metabolism of drugs cleared by CYP enzymes, though interactions are generally less significant than with other PPIs.
* **Amoxicillin:** May reduce the efficacy of oral contraceptives. Probenecid may increase and prolong blood levels of amoxicillin.
* **Clarithromycin:** A potent inhibitor of CYP3A4. Can increase serum concentrations of numerous drugs metabolized by CYP3A4, including statins, anticoagulants (e.g., warfarin), certain antiarrhythmics, benzodiazepines, and calcium channel blockers. Avoid concurrent use with colchicine, cisapride, domperidone, and pimozide due to risk of toxicity.
## Monitoring
* **Efficacy:** Confirmation of *H. pylori* eradication (e.g., urea breath test, stool antigen test) is recommended 4-6 weeks after completion of therapy.
* **Adverse Effects:** Monitor for signs and symptoms of hypersensitivity reactions, C. difficile infection, and liver dysfunction.
* **Drug Interactions:** Assess for potential interactions, especially when other CYP3A4 substrates are co-administered with clarithromycin.
## Clinical Pearls
* Ensure patient compliance with the full 7-day regimen. Incomplete treatment increases the risk of treatment failure and antibiotic resistance.
* Educate patients on the importance of taking medications as prescribed, including the timing relative to meals.
* Advise patients to report any new or worsening symptoms, including severe diarrhea, rash, or signs of allergic reaction.
* Consider local antibiotic resistance patterns when initiating therapy, although this combination is a standard first-line regimen.
* If a patient has a penicillin allergy, alternative *H. pylori* eradication regimens should be considered.
***
*This information is intended for healthcare professionals and does not substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before making clinical decisions.*
